Fecal Metabolite Quantitation for Rapid Assessment of the Gut Microbiome
Authors:
- Michael W. MullowneyMMMichael W. Mullowney
- Angelica MoranAMAngelica Moran
- Antonio HernandezAHAntonio Hernandez
- Mary McMillinMMMary McMillin
- Amber RoseARAmber Rose
- David MoranDMDavid Moran
- Jessica LittleJLJessica Little
- Bhakti K. PatelBPBhakti K. Patel
- Christopher J. LehmannCLChristopher J. Lehmann
- Matthew A. OdenwaldMOMatthew A. Odenwald
- Eric G. PamerEPEric G. Pamer
Preprint
Abstract
The intestinal microbiome is composed of myriad microbial species that produce metabolites that impact host health. While loss of bacterial species and beneficial metabolites from the fecal microbiome is associated with development of a range of diseases and medical complications, there are currently no diagnostic tests that rapidly identify individuals with microbiome deficiencies. Reduced concentrations of fecal butyrate and deoxycholic acid are associated with adverse clinical outcomes and result from the loss of a subset of health-associated bacterial species. We present a rapid diagnostic test based on 3-nitrophenylhydrazine derivatization and ultrahigh-performance liquid chromatography-mass spectrometry that measures fecal butyrate and deoxycholic acid concentrations as markers of microbiome function. A matrix-matched calibration curve was developed using a simulated fecal mixture to optimize accuracy and facilitate adherence to clinical laboratory regulations. The assay showed an analytical measurement range from 4.3–3030.1 µM (LLOQ = 9.75 µM) for butyrate and from 0.9– 64.9 µM (LLOQ = 0.9 µM) for deoxycholic acid. Precision demonstrated a coefficient of variation <15% at all QC levels tested. The assay can be performed in under an hour from extraction to provision of quantitative results, enabling the rapid identification of patients with defective microbiome function.Keywords
This publication has 13 references indexed in Scilit:
- Fecal metabolite profiling identifies liver transplant recipients at risk for postoperative infectionCell Host & Microbe, 2023
- Bifidobacteria metabolize lactulose to optimize gut metabolites and prevent systemic infection in patients with liver diseaseNature Microbiology, 2023
- Immunomodulatory fecal metabolites are associated with mortality in COVID-19 patients with respiratory failureNature Communications, 2022
- Development of an Efficient and Sensitive Chemical Derivatization-Based LC–MS/MS Method for Quantifying Gut Microbiota-Derived Metabolites in Human Plasma and Its Application in Studying Cardiovascular DiseaseJournal of Proteome Research, 2021
- Omics in gut microbiome analysisJournal of Microbiology, 2021
- Current Capabilities of Gut Microbiome–Based Diagnostics and the Promise of Clinical ApplicationThe Journal of Infectious Diseases, 2020
- Assessment of gut microbiota fecal metabolites by chromatographic targeted approachesJournal of Pharmaceutical and Biomedical Analysis, 2020
- Metabolomics analysis of human acute graft-versus-host disease reveals changes in host and microbiota-derived metabolitesNature Communications, 2019
- Impact of gut colonization with butyrate producing microbiota on respiratory viral infection following allo-HCTBlood, 2018
- Application of liquid chromatography–mass spectrometry to measure short chain fatty acids in bloodJournal of Chromatography B, 2009